Polaris Ultra
Device Polaris_IC
PDI 08714729124269
General payments
$16,264
Research payments
$50,000
Through program year 2025, $16,264 in general payments and $50,000 in research payments were reported against Polaris Ultra (Polaris_IC).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $65 | 3 |
| 2025 | Research | $25,000 | 1 |
| 2024 | General | $486 | 22 |
| 2024 | Research | $25,000 | 1 |
| 2023 | General | $1,180 | 47 |
| 2022 | General | $14,533 | 67 |
Breakdown
Each share is of general payments naming this product in 2025.
Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2025 where a state was reported.
Records
139 general · 2 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.